Enfusion Names Michael Spellacy as Board Chair and Non-Executive Director
Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, today announced that on January 9, 2023, its Board of Directors (the “Board”) had appointed Michael Spellacy, as Board Chair, effective immediately.
- Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, today announced that on January 9, 2023, its Board of Directors (the “Board”) had appointed Michael Spellacy, as Board Chair, effective immediately.
- “We are delighted with the addition of Michael Spellacy and are fortunate to have a leader with Mr. Spellacy’s strategic experience as our next Board chair.
- I can’t think of a more suitable candidate to lead the Board going forward,” said Kathleen DeRose, Interim Chair of the Board, on behalf of the Board of Directors.
- “I am excited to join this experienced, capable Board of Directors, and such a dynamic business, and to lead the Board as its new Chair at an important inflection point for the company”, said Mr. Spellacy.